Picture Berlin Partner Top News EIC Accelerator Noah Labs MyoPax 650x100px

Organisation › Details

Kite Pharma Inc.

https://www.kitepharma.com

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. *

	Start	2015-12-11 existent
	Group	Gilead Sciences (Group)
	Industry	cancer immunotherapy (immuno-oncology, I-O)
	Industry 2	eACT™ (engineered autologous T cell therapy)
	Person	Belldegrun, Arie (Allogene 201806 Executive Chairman before Kite Pharma CEO)

	Street	2225 Colorado Avenue
	City	90404 Santa Monica, CA
	Tel	+1-310-824-9999
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2025-01-23

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for Gilead Sciences (Group)

[1] NeoPhore Ltd.. (12/16/24). "Press Release: NeoPhore Appoints Michael Shih as Chief Executive Officer". London....
[2] Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich....
[3] Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna....
[4] Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen....
[5] Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna....
[6] Gilead Sciences, Inc.. (9/20/22). "Press Release: Gilead Sciences Completes Acquisition of MiroBio". Foster City, CA....
[7] MiroBio Ltd.. (8/4/22). "Press Release: Gilead Sciences to Acquire MiroBio". Foster City, CA & Oxford....
[8] Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen....
[9] BioNTech SE. (7/19/21). "Press Release: BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD". Mainz & Santo Monica, CA....
[10] Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]